{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s", "QSAR", "bioactive compounds", "molecular docking", "neurodegenerative diseases", "pharmacophore modeling"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33915968", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "24"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "04", "Day": "01"}], "Language": ["eng"], "ELocationID": ["1996", "10.3390/molecules26071996"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "7", "PubDate": {"Year": "2021", "Month": "Apr", "Day": "01"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.", "Abstract": {"AbstractText": ["Neurodegenerative diseases, for example Alzheimer's, are perceived as driven by hereditary, cellular, and multifaceted biochemical actions. Numerous plant products, for example flavonoids, are documented in studies for having the ability to pass the blood-brain barrier and moderate the development of such illnesses. Computer-aided drug design (CADD) has achieved importance in the drug discovery world; innovative developments in the aspects of structure identification and characterization, bio-computational science, and molecular biology have added to the preparation of new medications towards these ailments. In this study we evaluated nine flavonoid compounds identified from three medicinal plants, namely <i>T. diversifolia</i>, <i>B. sapida,</i> and <i>I. gabonensis</i> for their inhibitory role on acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and monoamine oxidase (MAO) activity, using pharmacophore modeling, auto-QSAR prediction, and molecular studies, in comparison with standard drugs. The results indicated that the pharmacophore models produced from structures of AChE, BChE and MAO could identify the active compounds, with a recuperation rate of the actives found near 100% in the complete ranked decoy database. Moreso, the robustness of the virtual screening method was accessed by well-established methods including enrichment factor (EF), receiver operating characteristic curve (ROC), Boltzmann-enhanced discrimination of receiver operating characteristic (BEDROC), and area under accumulation curve (AUAC). Most notably, the compounds' pIC<sub>50</sub> values were predicted by a machine learning-based model generated by the AutoQSAR algorithm. The generated model was validated to affirm its predictive model. The best models achieved for AChE, BChE and MAO were models kpls_radial_17 (R<sup>2</sup> = 0.86 and Q<sup>2</sup> = 0.73), pls_38 (R<sup>2</sup> = 0.77 and Q<sup>2</sup> = 0.72), kpls_desc_44 (R<sup>2</sup> = 0.81 and Q<sup>2</sup> = 0.81) and these externally validated models were utilized to predict the bioactivities of the lead compounds. The binding affinity results of the ligands against the three selected targets revealed that luteolin displayed the highest affinity score of -9.60 kcal/mol, closely followed by apigenin and ellagic acid with docking scores of -9.60 and -9.53 kcal/mol, respectively. The least binding affinity was attained by gallic acid (-6.30 kcal/mol). The docking scores of our standards were -10.40 and -7.93 kcal/mol for donepezil and galanthamine, respectively. The toxicity prediction revealed that none of the flavonoids presented toxicity and they all had good absorption parameters for the analyzed targets. Hence, these compounds can be considered as likely leads for drug improvement against the same."]}, "AuthorList": [{"Identifier": ["0000-0001-9331-396X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Biochemistry and Biochemical Toxicology Group, Department of Biochemistry, Landmark University, Omu-Aran PMB 1001, Nigeria."}], "LastName": "Ojo", "ForeName": "Oluwafemi Adeleke", "Initials": "OA"}, {"Identifier": ["0000-0003-1421-3819"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Sciences, Ekiti State University, Ado-Ekiti PMB 5363, Nigeria."}], "LastName": "Ojo", "ForeName": "Adebola Busola", "Initials": "AB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Landmark University, Omu-Aran PMB 1001, Nigeria."}], "LastName": "Okolie", "ForeName": "Charles", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Biochemistry and Biochemical Toxicology Group, Department of Biochemistry, Landmark University, Omu-Aran PMB 1001, Nigeria."}], "LastName": "Nwakama", "ForeName": "Mary-Ann Chinyere", "Initials": "MC"}, {"Identifier": ["0000-0001-5198-1441"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Biochemistry and Biochemical Toxicology Group, Department of Biochemistry, Landmark University, Omu-Aran PMB 1001, Nigeria."}], "LastName": "Iyobhebhe", "ForeName": "Matthew", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Landmark University, Omu-Aran PMB 1001, Nigeria."}], "LastName": "Evbuomwan", "ForeName": "Ikponmwosa Owen", "Initials": "IO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Biochemistry and Biochemical Toxicology Group, Department of Biochemistry, Landmark University, Omu-Aran PMB 1001, Nigeria."}], "LastName": "Nwonuma", "ForeName": "Charles Obiora", "Initials": "CO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Biochemistry and Biochemical Toxicology Group, Department of Biochemistry, Landmark University, Omu-Aran PMB 1001, Nigeria."}], "LastName": "Maimako", "ForeName": "Rotdelmwa Filibus", "Initials": "RF"}, {"Identifier": ["0000-0003-1349-9966"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Basic Medical Science, University of Jos, Jos PMB 2084, Nigeria."}], "LastName": "Adegboyega", "ForeName": "Abayomi Emmanuel", "Initials": "AE"}, {"Identifier": ["0000-0001-8752-3290"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Chrisland University, Abeokuta PMB 2131, Nigeria."}], "LastName": "Taiwo", "ForeName": "Odunayo Anthonia", "Initials": "OA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia."}], "LastName": "Alsharif", "ForeName": "Khalaf F", "Initials": "KF"}, {"Identifier": ["0000-0002-7817-425X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, AlBeheira 22511, Egypt."}], "LastName": "Batiha", "ForeName": "Gaber El-Saber", "Initials": "GE"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Butyrylcholinesterase"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": ["chemistry"], "DescriptorName": "Butyrylcholinesterase"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Drug Discovery"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": [], "DescriptorName": "Molecular Conformation"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Quantitative Structure-Activity Relationship"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Akobundu C., Agyakwa C.W. A Handbook of West African Weeds, Intec Printers, Ibadan. International Institute of Tropical Agriculture; Ibadan, Nigeria: 1998."}, {"Citation": "Goffin E., Ziemons E., De Mol P., De Madureira M.D.C., Martins A.P., Da Cunha A.P., Philippe G., Tits M., Angenot L., Fr\u00e9d\u00e9rich M. In Vitro Antiplasmodial Activity of Tithonia diversifolia and Identification of its Main Active Constituent: Tagitinin C. Planta Medica. 2002;68:543\u2013545. doi: 10.1055/s-2002-32552.", "ArticleIdList": ["10.1055/s-2002-32552", "12094301"]}, {"Citation": "Ojo O.A., Ojo A.B., Ajiboye B.O., Olaiya O., Okesola M.A., Boligon A.A., De Campos M.M.A., Oyinloye B.E., Kappo A.P. HPLC-DAD fingerprinting analysis, antioxidant activities of Tithonia diversifolia (Hemsl.) A. Gray leaves and its inhibition of key enzymes linked to Alzheimer\u2019s disease. Toxicol. Rep. 2018;5:585\u2013592. doi: 10.1016/j.toxrep.2018.05.003.", "ArticleIdList": ["10.1016/j.toxrep.2018.05.003", "PMC5977871", "29854628"]}, {"Citation": "Ojo O.A., Ojo A.B. Inhibitory activity of Tithonia diversifolia (Hemsl.) A. Gray leaves on some pro-oxidant induced oxidative stress in rat brain. Toxicol. Int. 2016;23:254\u2013259. doi: 10.22506/ti/2016/v23/i3/146719.", "ArticleIdList": ["10.22506/ti/2016/v23/i3/146719"]}, {"Citation": "Ojo O.A., Ajiboye B.O., Ojo A.B., Oyinloye B.E., Imiere O.D., Adeyonu O. Ameliorative potential of Blighia sapida K.D. Koenig bark against pancreatic \u03b2-cell dysfunction in alloxan-induced diabetic rats. J. Complement. Integr. Med. 2017;14 doi: 10.1515/jcim-2016-0145.", "ArticleIdList": ["10.1515/jcim-2016-0145", "28306534"]}, {"Citation": "Saidu A.N., Mann A., Ndako M. Phytochemical studies and effect of the aqueous extract of Blighia sapida stem bark on the liver enzymes of albino rats. Inter. Res. J. Biochem. Bioinform. 2013;3:104\u2013108."}, {"Citation": "Hamzah R., Egwim E., Kabiru A., Muazu M. Phytochemical and in vitro antioxidant properties of the methanolic extract of fruits of Blighia sapida, Vitellaria paradoxa and Vitex doniana. Oxid. Antioxidants Med. Sci. 2012;2:215\u2013221. doi: 10.5455/oams.090513.or.043.", "ArticleIdList": ["10.5455/oams.090513.or.043"]}, {"Citation": "Elufioye T. Ethnomedicinal study and screening of plants used for memory enhancement and Antiaging in Sagamu, Nigeria. Eur. J. Med. Plants. 2012;2:262\u2013275. doi: 10.9734/EJMP/2012/1372.", "ArticleIdList": ["10.9734/EJMP/2012/1372"]}, {"Citation": "Udobi C.E., Ubulom P.M., Akpabio E.I., Eshiet U. Antimicrobial Activities of Leaf and Stem Bark Extracts of Blighia. sapida. J. Plant Stud. 2013;2:47\u201352."}, {"Citation": "Ojo O.A., Ajiboye B.O., Ojo A.B., Olayide I.I., Akinyemi A.J., Fadaka A.O., Adedeji E.A., Boligon A.A., de Campos M.M. HPLC-DAD fingerprinting analysis, antioxidant activity of phenolic extracts from Blighia sapida bark and its inhibition of cholinergic enzymes linked to Alzheimer\u2019s disease. Jordan J. Biol. Sci. 2017;10:257\u2013264."}, {"Citation": "Ojo O.A., Ajiboye B.O., Imiere O.D., Adeyonu O., Olayide I.I., Fadaka O.A. Antioxidative Properties of Blighia sapida K.D. Koenig Stem Bark Extract and Inhibitory Effects on Carbohydrate Hydrolyzing Enzymes Associated with Non-Insulin Dependent Diabetes Mellitus. Pharmacogn. J. 2018;10:376\u2013383. doi: 10.5530/pj.2018.2.63.", "ArticleIdList": ["10.5530/pj.2018.2.63"]}, {"Citation": "Dienagha A.R., Miebi T.O. Energy requirements for cracking dika (Ogbono) nuts (Irvingia gabonensis) Eur. J. Sci Res. 2011;59:208\u2013215."}, {"Citation": "Ojo O.A., Oyinloye B.E., Ajiboye B.O., Onikanni S.A. Neuroprotective Mechanism of Ethanolic Extract of Irvingia gabonensis Stem Bark against Cadmium-induced Neurotoxicity in Rats. Br. J. Med. Med Res. 2014;4:5793\u20135805. doi: 10.9734/BJMMR/2014/12249.", "ArticleIdList": ["10.9734/BJMMR/2014/12249"]}, {"Citation": "Ojo O.A., Ajiboye B.O., Oyinloye B.E., Ojo A.B. Prophylactic Effects of Ethanolic Extract of Irvingia gabonensis Stem Bark against Cadmium-Induced Toxicity in Albino Rats. Adv. Pharm. 2014;2014:1\u20138."}, {"Citation": "Ojo O.A., Ajiboye B.O., Oyinloye B.E., Ojo O.A., Olarewaju O.I. Protective effect of Irvingia gabonensis stem bark extract on cadmium induced nephrotoxicity in rats. Interdiscip. Toxicol. 2014;7:208\u2013214. doi: 10.2478/intox-2014-0030.", "ArticleIdList": ["10.2478/intox-2014-0030", "PMC4436210", "26109902"]}, {"Citation": "Ojo O.A., Ojo A.B., Ajiboye B.O., Oyinloye B.E., Akinyemi A.J., Okesola M.A., Boligon A.A., de Campos M.M. Chromatographic fingerprint analysis, antioxidant properties, and inhibition of cholinergic enzymes (acetylcholinesterase and butyrylcholinesterase) of phenolic extracts from Irvingia gabonensis (Aubry-Lecomte ex O\u2019Rorke) Baill bark. J. Basic Clin. Physiol. Pharmacol. 2018;29:217\u2013224. doi: 10.1515/jbcpp-2017-0063.", "ArticleIdList": ["10.1515/jbcpp-2017-0063", "29381472"]}, {"Citation": "Mucke L. Neuroscience: Alzheimer\u2019s disease. Nature. 2009;461:895\u2013897. doi: 10.1038/461895a.", "ArticleIdList": ["10.1038/461895a", "19829367"]}, {"Citation": "Fargo K., Bleiler L. Alzheimer\u2019s association report: 2014 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2014;10:47\u201392."}, {"Citation": "Ojo O.A., Afon A.A., Ojo A.B., Ajiboye B.O., Okesola M.A., Aruleba R.T., Adekiya T.A., Oyinloye B.E. Spondias mombim L. (Anacardiaceae): Chemical fingerprints, inhibitory activities and molecular docking on key enzymes relevant to erectile dysfunction and Alzheimer\u2019s diseases. J. Food Biochem. 2019;43:e12772. doi: 10.1111/jfbc.12772.", "ArticleIdList": ["10.1111/jfbc.12772", "31353540"]}, {"Citation": "Konrath E.L., Passos C.S., Klein-Junior L.C., Henriques A.T. Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer\u2019s disease. J. Pharm. Pharmacol. 2013;65:1701\u20131725. doi: 10.1111/jphp.12090.", "ArticleIdList": ["10.1111/jphp.12090", "24236981"]}, {"Citation": "Ojo O.A., Ojo A.B., Ajiboye B.O., Olaiya O., Akawa A., Olaoye O., Anifowose O.O., Idowu O., Olasehinde O., Obafemi T., et al. Inhibitory effect of Bryophyllum pinnatum (Lam.) Oken leaf extract and their fractions on \u03b1-amylase, \u03b1-glucosidase and cholinesterase enzyme. Pharmacogn. J. 2018;10:497\u2013506."}, {"Citation": "Jacob S.N., Nienborg H. Monoaminergic Neuromodulation of Sensory Processing. Front. Neural Circuits. 2018;12:51. doi: 10.3389/fncir.2018.00051.", "ArticleIdList": ["10.3389/fncir.2018.00051", "PMC6048220", "30042662"]}, {"Citation": "Chandler D.J., Lamperski C.S., Waterhouse B.D. Identification and distribution of projections from monoaminergic and cholinergic nuclei to functionally differentiated subregions of prefrontal cortex. Brain Res. 2013;1522:38\u201358. doi: 10.1016/j.brainres.2013.04.057.", "ArticleIdList": ["10.1016/j.brainres.2013.04.057", "PMC3811940", "23665053"]}, {"Citation": "Toda N., Kaneko T., Kogen H. Development of an efficient therapeutic agent for Alzheimer\u2019s disease: Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter. Chem. Pharm. Bull. 2010;58:273\u2013287. doi: 10.1248/cpb.58.273.", "ArticleIdList": ["10.1248/cpb.58.273", "20190429"]}, {"Citation": "Pohanka M. Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity. Int. J. Mol. Sci. 2014;15:9809\u20139825. doi: 10.3390/ijms15069809.", "ArticleIdList": ["10.3390/ijms15069809", "PMC4100123", "24893223"]}, {"Citation": "Y\u0131lmaz S., Akbaba Y., Ozgeris B. Synthesis and inhibitory properties of some carbamates on carbonic anhydrase and acetylcholin esterase. J. Enzyme Inhib. Med. Chem. 2016;31:1484\u20131491. doi: 10.3109/14756366.2016.1149477.", "ArticleIdList": ["10.3109/14756366.2016.1149477", "26985691"]}, {"Citation": "Roy K., Chakraborty P., Mitra I., Ojha P.K., Kar S., Das R.N. Some case studies on application of \u201crm2\u201d metrics for judging quality of quantitative structure\u2013Activity relationship predictions: Emphasis on scaling of response data. J. Comput. Chem. 2013;34:1071\u20131082. doi: 10.1002/jcc.23231.", "ArticleIdList": ["10.1002/jcc.23231", "23299630"]}, {"Citation": "Puzyn T., Leszczynski J., Cronin M.T., editors. Recent Advances in QSAR Studies: Methods and Applications. Springer Science & Business Media; Berlin, Germany: 2010."}, {"Citation": "Colovic M.B., Krstic D.Z., Lazarevic P.T., Bondzic A.M., Vasic V.M. Acetylcholinesterase inhibitors: Pharmacology and toxicology. Curr. Neuropharmacol. 2013;11:315\u2013335. doi: 10.2174/1570159X11311030006.", "ArticleIdList": ["10.2174/1570159X11311030006", "PMC3648782", "24179466"]}, {"Citation": "Hossain T., Islam M.A., Pal R., Saha A. Exploring structural requirement and binding interactions of \u03b2-amyloid cleavage enzyme inhibitors using molecular modeling techniques. Med. Chem. Res. 2013;22:4766\u20134774. doi: 10.1007/s00044-013-0481-z.", "ArticleIdList": ["10.1007/s00044-013-0481-z"]}, {"Citation": "Jain P., Jadhav H.R. Quantitative structure activity relationship analysis of aminoimidazoles as BACE-I inhibitors. Med. Chem. Res. 2013;22:1740\u20131746. doi: 10.1007/s00044-012-0166-z.", "ArticleIdList": ["10.1007/s00044-012-0166-z"]}, {"Citation": "Ambure P., Roy K. Understanding the structural requirements of cyclic sulfone hydroxyethylamines as hBACE1 inhibitors against A\u03b2 plaques in Alzheimer\u2019s disease: A predictive QSAR approach. RSC Adv. 2016;6:28171\u201328186. doi: 10.1039/C6RA04104C.", "ArticleIdList": ["10.1039/C6RA04104C"]}, {"Citation": "Shen L.L., Liu G.X., Tang Y. Molecular docking and 3DQSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors. Acta Pharmacol. Sin. 2007;28:2053\u20132063. doi: 10.1111/j.1745-7254.2007.00664.x.", "ArticleIdList": ["10.1111/j.1745-7254.2007.00664.x", "18031622"]}, {"Citation": "Li Y.P., Weng X., Ning F.X., Ou J.B., Hou J.Q., Luo H.B., Li D., Huang Z.S., Huang S.L., Gu L.Q. 3D-QSAR studies of azaoxoisoaporphine, oxoaporphine, and oxoisoaporphine derivatives as antiAChE and anti-AD agents by the CoMFA method. J. Mol. Graph. Model. 2013;41:61\u201367. doi: 10.1016/j.jmgm.2013.02.003.", "ArticleIdList": ["10.1016/j.jmgm.2013.02.003", "23500628"]}, {"Citation": "Akula N., Lecanu L., Greeson J., Papadopoulos V. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA. Bioorganic Med. Chem. Lett. 2006;16:6277\u20136280. doi: 10.1016/j.bmcl.2006.09.030.", "ArticleIdList": ["10.1016/j.bmcl.2006.09.030", "17049234"]}, {"Citation": "Gharaghani S., Khayamian T., Ebrahimi M. Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors. SAR QSAR Environ. Res. 2013;24:773\u2013794. doi: 10.1080/1062936X.2013.792877.", "ArticleIdList": ["10.1080/1062936X.2013.792877", "23863115"]}, {"Citation": "Islam M.R., Zaman A., Jahan I., Chakravorty R., Chakrabo S. In silico QSAR analysis of quercetin reveals its potential as therapeutic drug for Alzheimer\u2019s disease. J. Young Pharma. 2013;5:173\u2013179. doi: 10.1016/j.jyp.2013.11.005.", "ArticleIdList": ["10.1016/j.jyp.2013.11.005", "PMC3930111", "24563598"]}, {"Citation": "Khatkar A., Nanda A., Kumar P., Narasimhan B. Synthesis, antimicrobial evaluation and QSAR studies of p-coumaric acid derivatives. Arab. J. Chem. 2017;10:S3804\u2013S3815. doi: 10.1016/j.arabjc.2014.05.018.", "ArticleIdList": ["10.1016/j.arabjc.2014.05.018"]}, {"Citation": "Mahmoodabadi N., Ajloo D. QSAR, docking and Molecular dynamic studies on the polyphenolic as inhibitors of \u03b2-amyloid aggregation. Med. Chem. Res. 2016;25:2104\u20132118. doi: 10.1007/s00044-016-1620-0.", "ArticleIdList": ["10.1007/s00044-016-1620-0"]}, {"Citation": "Malik N., Khatkar A. 3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors. Curr. Neuropharmacol. 2018;16:881\u2013900.", "ArticleIdList": ["PMC6080100", "29189167"]}, {"Citation": "Das S., Laskar M.A., Sarker S.D., Choudhury M.D., Choudhury P.R., Mitra A., Jamil S., Lathiff S.M.A., Abdullah S.A., Basar N., et al. Prediction of Anti-Alzheimer\u2019s Activity of Flavonoids Targeting Acetylcholinesterase in silico. Phytochem. Anal. 2017;28:324\u2013331. doi: 10.1002/pca.2679.", "ArticleIdList": ["10.1002/pca.2679", "28168765"]}, {"Citation": "Mukesh S., Dharmendra A. QSAR Studies of Flavonoids Derivatives for Antioxidant and Antimicrobial Activity. J. Drug Deliv. Ther. 2019;9:765\u2013773."}, {"Citation": "Kondeva-Burdina M., Doytchinova I., Krasteva I., Ionkova I., Manov V. Hepato-, neuroprotective effects and QSAR studies on flavoalkaloids and flavonoids from Astragalus monspessulanus. Biotechnol. Biotechnol. Equip. 2019;33:1434\u20131443. doi: 10.1080/13102818.2019.1673209.", "ArticleIdList": ["10.1080/13102818.2019.1673209"]}, {"Citation": "Chakraborty S., Basu S. Multi-functional activities of citrus flavonoid narirutin in Alzheimer\u2019s disease therapeutics: An integrated screening approach and in vitro validation. Int. J. Biol. Macromol. 2017;103:733\u2013743. doi: 10.1016/j.ijbiomac.2017.05.110.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.05.110", "28528948"]}, {"Citation": "Abdizadeh R., Hadizadeh F., Abdizadeh T. Molecular modeling studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques. Med. Chem. 2020;16:903\u2013927. doi: 10.2174/1573406415666190806155619.", "ArticleIdList": ["10.2174/1573406415666190806155619", "31385775"]}, {"Citation": "Dixon S.L., Smondyrev A.M., Knoll E.H., Rao S.N., Shaw D.E., Friesner R.A. PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J. Comput. Aided Mol. Des. 2006;20:647\u2013671. doi: 10.1007/s10822-006-9087-6.", "ArticleIdList": ["10.1007/s10822-006-9087-6", "17124629"]}, {"Citation": "Loving K., Salam N.K., Sherman W. Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation. J. Comput. Aided Mol. Des. 2009;23:541\u2013554. doi: 10.1007/s10822-009-9268-1.", "ArticleIdList": ["10.1007/s10822-009-9268-1", "19421721"]}, {"Citation": "Ojo O.A. Puerarin as a potential drug candidate for the treatment of Diabetes mellitus: Molecular docking and Pharmacophore Modelling studies. Biointerface Res. Appl. Chem. 2021;11:8751\u20138759."}, {"Citation": "Palakurti R., Sriram D., Yogeeswari P., Vadrevu R. Multiple e-Pharmacophore Modeling Combined with High-Throughput Virtual Screening and Docking to Identify Potential Inhibitors of \u03b2-Secretase(BACE1) Mol. Inform. 2013;32:385\u2013398. doi: 10.1002/minf.201200169.", "ArticleIdList": ["10.1002/minf.201200169", "27481595"]}, {"Citation": "Tripathia A.C., Sonara P.K., Rathoreb R., Sarafa S.K. Structural Insights into the Molecular Design of HER2 Inhibitors. Open Pharm. Sci. J. 2016;3:164\u2013181. doi: 10.2174/1874844901603010164.", "ArticleIdList": ["10.2174/1874844901603010164"]}, {"Citation": "Arthur D.E., Ejeh S., Uzairu A. Quantitative structure-activity relationship (QSAR) and design of novel ligands that demonstrate high potency and target selectivity as protein tyrosine phosphatase 1B (PTP 1B) inhibitors as an effective strategy used to model anti-diabetic agents. J. Recept. Signal Transduct. 2020;40:501\u2013520. doi: 10.1080/10799893.2020.1759092.", "ArticleIdList": ["10.1080/10799893.2020.1759092", "32397858"]}, {"Citation": "Dixon S.L., Smondyrev A.M., Rao S.N. PHASE: A novel approach to pharmacophore modeling and 3D database searching. Chem. Biol. Drug Des. 2006;67:370\u2013372. doi: 10.1111/j.1747-0285.2006.00384.x.", "ArticleIdList": ["10.1111/j.1747-0285.2006.00384.x", "16784462"]}, {"Citation": "Sheridan R.P., Singh S.B., Fluder E.M., Kearsley S.K. Protocols for bridging the peptide to nonpeptide gap in topological similarity searches. J. Chem. Inf. Comp. Sci. 2001;41:1395\u20131406. doi: 10.1021/ci0100144.", "ArticleIdList": ["10.1021/ci0100144", "11604041"]}, {"Citation": "Kumar V., Ojha P.K., Saha A., Roy K. Exploring 2D-QSAR for prediction of beta-secretase 1 (BACE1) inhibitory activity against Alzheimer\u2019s disease. SAR QSAR Environ. Res. 2020;31:87\u2013133. doi: 10.1080/1062936X.2019.1695226.", "ArticleIdList": ["10.1080/1062936X.2019.1695226", "31865778"]}, {"Citation": "Yasri A., Hartsough D.J. Toward an optimal procedure for variable selection and QSAR modeling building. Chem. Inf. Comput. Sci. 2001;41:1218\u20131227. doi: 10.1021/ci010291a.", "ArticleIdList": ["10.1021/ci010291a", "11604021"]}, {"Citation": "Martin Y.C. A bioavailability score. J. Med. Chem. 2005;48:3164\u20133170. doi: 10.1021/jm0492002.", "ArticleIdList": ["10.1021/jm0492002", "15857122"]}, {"Citation": "Golbraikh A., Tropsha A. Beware of q2! J. Mol. Graph. Model. 2002;20:269\u2013276. doi: 10.1016/S1093-3263(01)00123-1.", "ArticleIdList": ["10.1016/S1093-3263(01)00123-1", "11858635"]}, {"Citation": "Golbraikh A., Tropsha A. Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. J. Comput. Mol. Des. 2002;16:357\u2013369. doi: 10.1023/A:1020869118689.", "ArticleIdList": ["10.1023/A:1020869118689", "12489684"]}, {"Citation": "Veerasamy R., Rajak H., Jain A., Sivadasan S., Varghese C., Agrawal R. Validation of QSAR models-strategies and importance. Int. J. Drug Des. Discov. 2011;2:511\u2013519."}, {"Citation": "Ertl P., Schuffenhauer A. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J. Cheminformatics. 2009;1:1\u201311. doi: 10.1186/1758-2946-1-8.", "ArticleIdList": ["10.1186/1758-2946-1-8", "PMC3225829", "20298526"]}, {"Citation": "Ojo O.A., Aruleba R.T., Adekiya T.A., Sibuyi N.R.S., Ojo A.B., Ajiboye B.O., Oyinloye B.E., Adeola H.A., Fadaka A.O. Deciphering the interaction of puerarin with cancer macromolecules: An in silico investigation. J. Biomol. Struct. Dyn. 2020:1\u201312. doi: 10.1080/07391102.2020.1819425.", "ArticleIdList": ["10.1080/07391102.2020.1819425", "32924840"]}, {"Citation": "Priyadarshini V., Pradhan D., Munikumar M., Swargam S., Umamaheswari A., Rajasekhar D. Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis. J. Biomol. Struct. Dyn. 2014;32:876\u2013889. doi: 10.1080/07391102.2013.795871.", "ArticleIdList": ["10.1080/07391102.2013.795871", "24404767"]}, {"Citation": "Glue P., Clement R.P. Cytochrome P450 Enzymes and Drug Metabolism\u2014Basic Concepts and Methods of Assessment. Cell. Mol. Neurobiol. 1999;19:309\u2013323. doi: 10.1023/A:1006993631057.", "ArticleIdList": ["10.1023/A:1006993631057", "10319190"]}, {"Citation": "Dixit B. A review on the effects of CMPF binding with Human Serum Albumin. Bioinform. Rev. 2017;3:9\u201318."}, {"Citation": "Radchenko E.V., Dyabina A.S., Palyulin V.A., Zefirov N.S. Prediction of human intestinal absorption of drug compounds. Russ. Chem. Bull. 2016;65:576\u2013580. doi: 10.1007/s11172-016-1340-0.", "ArticleIdList": ["10.1007/s11172-016-1340-0"]}, {"Citation": "Wessel M.D., Jurs P.C., Tolan J.W., Muskal S.M. Prediction of human intestinal absorption of drug compounds from molecular structure. J. Chem. Inf. Comput. Sci. 1998;38:726\u2013735. doi: 10.1021/ci980029a.", "ArticleIdList": ["10.1021/ci980029a", "9691477"]}, {"Citation": "Basant N., Gupta S., Singh K.P. Predicting human intestinal absorption of diverse chemicals using ensemble learning based QSAR modeling approaches. Comput. Biol. Chem. 2016;61:178\u2013196. doi: 10.1016/j.compbiolchem.2016.01.005.", "ArticleIdList": ["10.1016/j.compbiolchem.2016.01.005", "26881740"]}, {"Citation": "Swierczewska M., Lee K.C., Lee S. What is the future of PEGylated therapies? Expert Opin. Emerg. Drugs. 2015;20:531\u2013536. doi: 10.1517/14728214.2015.1113254.", "ArticleIdList": ["10.1517/14728214.2015.1113254", "PMC4908577", "26583759"]}, {"Citation": "Wang X., Shen Y., Wang S., Li S., Zhang W., Liu X., Lai L., Pei J., Li H. PharmMapper 2017 update: A web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017;45:W356\u2013W360. doi: 10.1093/nar/gkx374.", "ArticleIdList": ["10.1093/nar/gkx374", "PMC5793840", "28472422"]}, {"Citation": "Lynch T., Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am. Fam. Physician. 2007;76:391\u2013396.", "ArticleIdList": ["17708140"]}, {"Citation": "Chow H.S., Garland L.L., Hsu C.H., Vining D.R., Chew W.M., Miller J.A., Perloff M., Crowell J.A., Alberts D.S. Resveratrol modulates drug-and carcinogen metabolizing enzymes in a healthy volunteer study. Cancer Prev. Res. 2010;3:1168\u20131175. doi: 10.1158/1940-6207.CAPR-09-0155.", "ArticleIdList": ["10.1158/1940-6207.CAPR-09-0155", "PMC2933312", "20716633"]}, {"Citation": "Khan M.F., Bari M.A., Islam M.K., Islam M.S., Kayser M.S., Nahar N., Al-Faruk M., Rashid M.A. The natural anti-tubercular agents: In silico study of physicochemical, pharmacokinetic and toxicological properties. J. App. Pharm. Sci. 2017;7:34\u201338."}, {"Citation": "Sahin S., Benet L.Z. The operational multiple dosing half-life: A key to defining drug accumulation in patients and to designing extended release dosage forms. Pharm. Res. 2008;25:2869\u20132877. doi: 10.1007/s11095-008-9787-9.", "ArticleIdList": ["10.1007/s11095-008-9787-9", "PMC3581066", "19015955"]}, {"Citation": "Cheng A., Dixon S.L. In silico models for the prediction of dose-dependent human hepatotoxicity. J. Comput. Aid Mol. Des. 2003;17:811\u2013823. doi: 10.1023/B:JCAM.0000021834.50768.c6.", "ArticleIdList": ["10.1023/B:JCAM.0000021834.50768.c6", "15124930"]}, {"Citation": "Saddala M.S., Obaiah J., Rani A.U. Identification of potent VEGFR-2 Inhibitors of Angiogenesis through homology modeling, structure based virtual screening, docking and molecular dynamics simulations. Int. J. Sci. Eng. Res. 2015;6:1382\u20131390."}, {"Citation": "Radwan A.A., Alanazi F.K. In silico studies on novel inhibitors of MERS-CoV: Structure-based pharmacophore modeling, database screening and molecular docking. Trop. J. Pharm. Res. 2018;17:513\u2013517. doi: 10.4314/tjpr.v17i3.18.", "ArticleIdList": ["10.4314/tjpr.v17i3.18"]}, {"Citation": "Schr\u00f6dinger Release . 2020-1: LigPrep 2020 Schr\u00f6dinger. LLC; New York, NY, USA: 2020."}, {"Citation": "Sander T., Freyss J., von Korff M., Rufener C. Data warrior: An open-source program for chemistry aware data visualization and analysis. J. Chem. Inf. Model. 2005;55:460\u2013473. doi: 10.1021/ci500588j.", "ArticleIdList": ["10.1021/ci500588j", "25558886"]}, {"Citation": "Schr\u00f6dinger Release . 2020-1: PHASE 2020 Schr\u00f6dinger. LLC; New York, NY, USA: 2020."}, {"Citation": "Duan J., Dixon S.L., Lowrie J.F., Sherman W. Analysis and comparison of 2D fingerprints; insights into database screening performance using eight fingerprint method. J. Mol. Graph. Model. 2010;29:157\u2013170. doi: 10.1016/j.jmgm.2010.05.008.", "ArticleIdList": ["10.1016/j.jmgm.2010.05.008", "20579912"]}, {"Citation": "de Oliveria M.T., Katekawa E. On the virtues of automated QSAR\u2014the new kid on the block. Future Med. Chem. 2018;10:335\u2013342. doi: 10.4155/fmc-2017-0170.", "ArticleIdList": ["10.4155/fmc-2017-0170", "29393678"]}, {"Citation": "Sepay N., Al Hoque A., Mondal R., Halder U., Muddassir M. In silico fight against novel coronavirus by finding chromone derivatives as inhibitor of coronavirus main proteases enzyme. Struct. Chem. 2020;31:1831\u20131840. doi: 10.1007/s11224-020-01537-5.", "ArticleIdList": ["10.1007/s11224-020-01537-5", "PMC7220622", "32412544"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "15"}, {"Year": "2021", "Month": "3", "Day": "22"}, {"Year": "2021", "Month": "3", "Day": "29"}, {"Year": "2021", "Month": "4", "Day": "30", "Hour": "1", "Minute": "1"}, {"Year": "2021", "Month": "5", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["33915968", "PMC8037217", "10.3390/molecules26071996", "molecules26071996"]}}], "PubmedBookArticle": []}